J Kevin Buchi Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity
J Kevin Buchi is Director of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of AMRX, which is worth approximately $0. The most recent transaction as insider was on Mar 10, 2025, when has been sold 262,072 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
100.0%
3M change
100.0%
12M change
Total Value Held
$0
J KEVIN BUCHI Transaction History
Also insider at
JKB
J Kevin Buchi
Director
Boston, MA